About investor relations

Corporate
Henry Schein at a Glance

About investor relations

$12.6B IN SALES IN 2022

12.1% COMPOUND ANNUAL GROWTH RATE SINCE 1995

Our Q2 Results Reflect

  • Q2 results driven by our North America dental businesses and continuing strength in sales of our technology and value-added services businesses
  • Our financial results and guidance demonstrate the strength of the business and continued advancement of our 2022-2024 BOLD+1 Strategic Plan
  • Affirming our 2023 full-year non-GAAP diluted EPS financial guidance

At Henry Schein, Inc., our customers rely on us for an exceptional experience

Delivering differentiated solutions that make their practices more successful and improve patient outcomes. We are trusted advisors and consultants to our customers – enabling them to deliver the best quality patient care and enhance their practice management efficiency and profitability.

With more than 3,400 field sales consultants (including equipment sales specialists), approximately 2,100 telesales representatives, and more than 170 equipment sales and service centers worldwide, Henry Schein helps customers succeed by offering the products and services needed for delivering high-quality health care.

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.